Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Apoptosis and autoimmunity [[electronic resource] /] / edited by M. Hermann and J.R. Kalden
| Apoptosis and autoimmunity [[electronic resource] /] / edited by M. Hermann and J.R. Kalden |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, c2003 |
| Descrizione fisica | 1 online resource (405 p.) |
| Disciplina |
571.9/73
616.97/8 616.978 |
| Altri autori (Persone) |
HerrmannM, Dr. (Martin)
KaldenJ. R (Joachim Robert) |
| Soggetto topico |
Apoptosis
Autoimmunity Autoimmune diseases |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-52038-8
9786610520381 3-527-60529-0 3-527-60145-7 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Apoptosis and Autoimmunity; Preface; Contents; List of Contributors; Part 1 General Features of Apoptosis; 1 Apoptosis and Autoimmunity; 1.1 Introduction; 1.2 Autoimmune Diseases Associated with Targeted Cell Destruction; 1.2.1 What is the Mode of Cell Death?; 1.2.2 What Cells and What Effector Pathways are Responsible for Cell Death?; 1.3 Autoimmune Diseases Associated with Enhanced Cell Growth and Survival; 1.4 Autoimmune Diseases Associated with Abnormal Processing of Dying Cells; 1.5 Conclusions; 1.6 References; 2 Caspase Knockouts: Matters of Life and Death
2.1 Death, Development and Immune Function2.2 Apoptotic Pathways: from Nematode to Mammals; 2.3 Triggering a Killer: General Aspects of Caspase Activation; 2.4 Caspase-1 and -11: More than Mediators of Inflammatory Cytokines?; 2.5 Caspase-8 and the FAS Signaling Pathway; 2.6 Caspase-3: The Chief Executioner?; 2.7 Caspase-9: Mitochondrial Activation and the Apoptosome; 2.8 Caspase-2: A Duality of Function; 2.9 Caspase-12: Responding to Stress; 2.10 Compensatory Caspase Activation: A Caveat to Knockout Analysis; 2.11 Caspases: More than Simple Killers; 2.12 Concluding Remarks; 2.13 References Part 2 Clearance of Apoptotic Cells3 Anti-inflammatory and Immunoregulatory Effects of Apoptotic Cells; 3.1 Introduction; 3.2 Anti-inflammatory Effects of Apoptotic Cells on Monocytes/Macrophages; 3.3 The Role of Anti-inflammatory Cytokines for the Inhibition of Pro-inflammatory Cytokine Production; 3.4 Monocyte/Macrophage Receptors receiving the Anti-inflammatory Signal from Apoptotic Cells; 3.5 Intracellular Signaling Events Causing the Anti-inflammatory State in Macrophages; 3.6 Apoptotic Cells Impair MHC Class II Surface Expression on Monocytes 3.7 Influence of Apoptotic Cells on DC Function in Allogeneic MLR3.8 The Presence of Apoptotic Cells can Shift the T(h) Cell Response towards T(h)2; 3.9 Apoptotic Cells Suppress Delayed-type Hypersensitivity (DTH) In Vivo; 3.10 Necrosis and Inflammation; 3.11 Implications of the Anti-inflammatory and Immunodulatory Effects of Apoptotic Cells for Health and Disease; 3.11.1 Apoptosis and Pregnancy; 3.11.2 Apoptosis and Irradiation; 3.11.3 Apoptosis and Cancer; 3.11.4 Apoptosis and Infections; 3.11.5 Apoptosis and Blood Transfusions; 3.12 References; 4 Complement and Apoptosis; 4.1 Introduction 4.2 Programmed Cell Death (PCD)4.3 Complement; 4.4 Complement and Apoptosis; 4.4.1 Role of Complement in the Execution Phase; 4.4.2 Complement Activation by Apoptotic Cells; 4.5 Apoptosis, Complement and Autoimmunity; 4.6 References; 5 Soluble Factors that Bind to Dying Cells Control the Outcome of Corpse Disposal: The Role of Pentraxins, Collectins and Autoantibodies; 5.1 Introduction; 5.2 Soluble Factors Involved in Apoptotic Cell Recognition and Internalization; 5.2.1 Corpse Clearance at Rest: Collectins; 5.2.2 Corpse Clearance at Rest: Cationic Factors and Other PS-binding Moieties 5.2.3 Corpse Clearance during Acute Inflammation: Pentraxins |
| Record Nr. | UNINA-9910146242903321 |
| Weinheim, : Wiley-VCH, c2003 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Apoptosis and autoimmunity [[electronic resource] /] / edited by M. Hermann and J.R. Kalden
| Apoptosis and autoimmunity [[electronic resource] /] / edited by M. Hermann and J.R. Kalden |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, c2003 |
| Descrizione fisica | 1 online resource (405 p.) |
| Disciplina |
571.9/73
616.97/8 616.978 |
| Altri autori (Persone) |
HerrmannM, Dr. (Martin)
KaldenJ. R (Joachim Robert) |
| Soggetto topico |
Apoptosis
Autoimmunity Autoimmune diseases |
| ISBN |
1-280-52038-8
9786610520381 3-527-60529-0 3-527-60145-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Apoptosis and Autoimmunity; Preface; Contents; List of Contributors; Part 1 General Features of Apoptosis; 1 Apoptosis and Autoimmunity; 1.1 Introduction; 1.2 Autoimmune Diseases Associated with Targeted Cell Destruction; 1.2.1 What is the Mode of Cell Death?; 1.2.2 What Cells and What Effector Pathways are Responsible for Cell Death?; 1.3 Autoimmune Diseases Associated with Enhanced Cell Growth and Survival; 1.4 Autoimmune Diseases Associated with Abnormal Processing of Dying Cells; 1.5 Conclusions; 1.6 References; 2 Caspase Knockouts: Matters of Life and Death
2.1 Death, Development and Immune Function2.2 Apoptotic Pathways: from Nematode to Mammals; 2.3 Triggering a Killer: General Aspects of Caspase Activation; 2.4 Caspase-1 and -11: More than Mediators of Inflammatory Cytokines?; 2.5 Caspase-8 and the FAS Signaling Pathway; 2.6 Caspase-3: The Chief Executioner?; 2.7 Caspase-9: Mitochondrial Activation and the Apoptosome; 2.8 Caspase-2: A Duality of Function; 2.9 Caspase-12: Responding to Stress; 2.10 Compensatory Caspase Activation: A Caveat to Knockout Analysis; 2.11 Caspases: More than Simple Killers; 2.12 Concluding Remarks; 2.13 References Part 2 Clearance of Apoptotic Cells3 Anti-inflammatory and Immunoregulatory Effects of Apoptotic Cells; 3.1 Introduction; 3.2 Anti-inflammatory Effects of Apoptotic Cells on Monocytes/Macrophages; 3.3 The Role of Anti-inflammatory Cytokines for the Inhibition of Pro-inflammatory Cytokine Production; 3.4 Monocyte/Macrophage Receptors receiving the Anti-inflammatory Signal from Apoptotic Cells; 3.5 Intracellular Signaling Events Causing the Anti-inflammatory State in Macrophages; 3.6 Apoptotic Cells Impair MHC Class II Surface Expression on Monocytes 3.7 Influence of Apoptotic Cells on DC Function in Allogeneic MLR3.8 The Presence of Apoptotic Cells can Shift the T(h) Cell Response towards T(h)2; 3.9 Apoptotic Cells Suppress Delayed-type Hypersensitivity (DTH) In Vivo; 3.10 Necrosis and Inflammation; 3.11 Implications of the Anti-inflammatory and Immunodulatory Effects of Apoptotic Cells for Health and Disease; 3.11.1 Apoptosis and Pregnancy; 3.11.2 Apoptosis and Irradiation; 3.11.3 Apoptosis and Cancer; 3.11.4 Apoptosis and Infections; 3.11.5 Apoptosis and Blood Transfusions; 3.12 References; 4 Complement and Apoptosis; 4.1 Introduction 4.2 Programmed Cell Death (PCD)4.3 Complement; 4.4 Complement and Apoptosis; 4.4.1 Role of Complement in the Execution Phase; 4.4.2 Complement Activation by Apoptotic Cells; 4.5 Apoptosis, Complement and Autoimmunity; 4.6 References; 5 Soluble Factors that Bind to Dying Cells Control the Outcome of Corpse Disposal: The Role of Pentraxins, Collectins and Autoantibodies; 5.1 Introduction; 5.2 Soluble Factors Involved in Apoptotic Cell Recognition and Internalization; 5.2.1 Corpse Clearance at Rest: Collectins; 5.2.2 Corpse Clearance at Rest: Cationic Factors and Other PS-binding Moieties 5.2.3 Corpse Clearance during Acute Inflammation: Pentraxins |
| Record Nr. | UNINA-9910830049703321 |
| Weinheim, : Wiley-VCH, c2003 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Apoptosis and autoimmunity / / edited by M. Hermann and J.R. Kalden
| Apoptosis and autoimmunity / / edited by M. Hermann and J.R. Kalden |
| Pubbl/distr/stampa | Weinheim, : Wiley-VCH, c2003 |
| Descrizione fisica | 1 online resource (405 p.) |
| Disciplina | 571.9/73 |
| Altri autori (Persone) |
HerrmannM, Dr. (Martin)
KaldenJ. R (Joachim Robert) |
| Soggetto topico |
Apoptosis
Autoimmunity Autoimmune diseases |
| ISBN |
1-280-52038-8
9786610520381 3-527-60529-0 3-527-60145-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Apoptosis and Autoimmunity; Preface; Contents; List of Contributors; Part 1 General Features of Apoptosis; 1 Apoptosis and Autoimmunity; 1.1 Introduction; 1.2 Autoimmune Diseases Associated with Targeted Cell Destruction; 1.2.1 What is the Mode of Cell Death?; 1.2.2 What Cells and What Effector Pathways are Responsible for Cell Death?; 1.3 Autoimmune Diseases Associated with Enhanced Cell Growth and Survival; 1.4 Autoimmune Diseases Associated with Abnormal Processing of Dying Cells; 1.5 Conclusions; 1.6 References; 2 Caspase Knockouts: Matters of Life and Death
2.1 Death, Development and Immune Function2.2 Apoptotic Pathways: from Nematode to Mammals; 2.3 Triggering a Killer: General Aspects of Caspase Activation; 2.4 Caspase-1 and -11: More than Mediators of Inflammatory Cytokines?; 2.5 Caspase-8 and the FAS Signaling Pathway; 2.6 Caspase-3: The Chief Executioner?; 2.7 Caspase-9: Mitochondrial Activation and the Apoptosome; 2.8 Caspase-2: A Duality of Function; 2.9 Caspase-12: Responding to Stress; 2.10 Compensatory Caspase Activation: A Caveat to Knockout Analysis; 2.11 Caspases: More than Simple Killers; 2.12 Concluding Remarks; 2.13 References Part 2 Clearance of Apoptotic Cells3 Anti-inflammatory and Immunoregulatory Effects of Apoptotic Cells; 3.1 Introduction; 3.2 Anti-inflammatory Effects of Apoptotic Cells on Monocytes/Macrophages; 3.3 The Role of Anti-inflammatory Cytokines for the Inhibition of Pro-inflammatory Cytokine Production; 3.4 Monocyte/Macrophage Receptors receiving the Anti-inflammatory Signal from Apoptotic Cells; 3.5 Intracellular Signaling Events Causing the Anti-inflammatory State in Macrophages; 3.6 Apoptotic Cells Impair MHC Class II Surface Expression on Monocytes 3.7 Influence of Apoptotic Cells on DC Function in Allogeneic MLR3.8 The Presence of Apoptotic Cells can Shift the T(h) Cell Response towards T(h)2; 3.9 Apoptotic Cells Suppress Delayed-type Hypersensitivity (DTH) In Vivo; 3.10 Necrosis and Inflammation; 3.11 Implications of the Anti-inflammatory and Immunodulatory Effects of Apoptotic Cells for Health and Disease; 3.11.1 Apoptosis and Pregnancy; 3.11.2 Apoptosis and Irradiation; 3.11.3 Apoptosis and Cancer; 3.11.4 Apoptosis and Infections; 3.11.5 Apoptosis and Blood Transfusions; 3.12 References; 4 Complement and Apoptosis; 4.1 Introduction 4.2 Programmed Cell Death (PCD)4.3 Complement; 4.4 Complement and Apoptosis; 4.4.1 Role of Complement in the Execution Phase; 4.4.2 Complement Activation by Apoptotic Cells; 4.5 Apoptosis, Complement and Autoimmunity; 4.6 References; 5 Soluble Factors that Bind to Dying Cells Control the Outcome of Corpse Disposal: The Role of Pentraxins, Collectins and Autoantibodies; 5.1 Introduction; 5.2 Soluble Factors Involved in Apoptotic Cell Recognition and Internalization; 5.2.1 Corpse Clearance at Rest: Collectins; 5.2.2 Corpse Clearance at Rest: Cationic Factors and Other PS-binding Moieties 5.2.3 Corpse Clearance during Acute Inflammation: Pentraxins |
| Record Nr. | UNINA-9910876627803321 |
| Weinheim, : Wiley-VCH, c2003 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The epigenetics of autoimmune diseases [[electronic resource] /] / edited by Moncef Zouali
| The epigenetics of autoimmune diseases [[electronic resource] /] / edited by Moncef Zouali |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, NJ, : Wiley-Blackwell, 2009 |
| Descrizione fisica | 1 online resource (473 p.) |
| Disciplina |
571.9/73
571.973 616.978042 |
| Altri autori (Persone) | ZoualiMoncef <1952-> |
| Soggetto topico |
Autoimmunity - Molecular aspects
Autoimmune diseases - Etiology Post-translational modification Epigenesis |
| ISBN |
1-282-13817-0
9786612138171 0-470-74355-7 0-470-74356-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
The Epigenetics of Autoimmune Diseases; Contents; Preface; Contributors; PART I Transcription Factors: Partners of Immune Tolerance to Self; 1 Transcriptional regulation of T cell tolerance; 1.1 Introduction; 1.2 T cell anergy; 1.3 Ca2+/calcineurin/NFAT signalling in T cell anergy; 1.4 Transcriptional programme of T cell anergy; 1.5 Transcriptional repression in T cell anergy: epigenetic modification of the Il2 promoter; 1.6 Regulatory T cells; 1.7 Transcriptional control of Treg development and function; References; 2 Epigenetic regulation of Foxp3 expression in regulatory T cells
2.1 Introduction2.2 Naturally occurring CD25+ CD4+ Tregs; 2.3 The transcription factor FOXP3: determining Treg function and identity; 2.4 Molecular regulation of FOXP3; 2.5 Tregs as a stable lineage: indications of epigenetic imprinting; 2.6 Induced Tregs: stable suppressors or transient immuno-modulators?; 2.7 Conclusions; References; 3 The role of NF-kB in central tolerance; 3.1 Introduction; 3.2 Canonical and alternative NF-kB pathways; 3.3 Thymic stroma and central tolerance; 3.4 NF-kB and regulatory T cell development; 3.5 NF-kB and thymocyte positive and negative selection 3.6 Conclusions and perspectives3.7 Acknowledgement; References; 4 The role of Act1 in the control of autoimmunity; 4.1 Introduction; 4.2 Autoimmunity and autoimmune mouse models; 4.3 Molecular mechanisms of autoimmunity; 4.4 Act1: a modulator of autoimmunity; 4.5 Conclusions; References; 5 Regulation of T cell anergy and escape from regulatory T cell suppression by Cbl-b; 5.1 Introduction; 5.2 Mechanisms of T cell tolerance induction; 5.3 Molecular establishment of T cell anergy; 5.4 Ubiquitin E3 ligases in T cell tolerance; 5.5 Molecular function and regulation of Cbl-b 5.6 Physiological relevance of Cbl-b5.7 The role of Cbl-b in T cell tolerance; 5.8 Deregulation of Cbl-b in disease; 5.9 Therapeutic potential of Cbl-b in tumour immunity; 5.10 Implications for autoimmune disease; References; 6 Indoleamine 2,3-dioxygenase: transcriptional regulation and autoimmunity; 6.1 Introduction; 6.2 L-Trp degradation along the kynurenine pathway and immune functions of IDO; 6.3 IDO immunobiology and therapeutic intervention; 6.4 Transcriptional regulation of the IDO-encoding gene; 6.5 Impaired IDO activity and loss of tolerance in autoimmune diseases 6.6 IDO-based therapies for autoimmune disease6.7 Acknowledgement; References; PART II Stress Responses that Break Immune Silence; 7 Chromatin modifications, oxidative stress and nucleosome autoantibodies; 7.1 Introduction; 7.2 Nucleosome and SLE; 7.3 Epigenetics and SLE; 7.4 Oxidative stress in SLE: definition and mechanisms; 7.5 Oxidative stress, epigenetic alterations and nucleosome immunogenicity; 7.6 Conclusion; 7.7 Acknowledgements; References; 8 Stress, epigenetics and thyroid autoimmunity; 8.1 Introduction; 8.2 The Th1/Th2 balance in immune-response regulation 8.3 Stress hormones and the Th1/Th2 balance |
| Record Nr. | UNINA-9910146133703321 |
| Chichester ; ; Hoboken, NJ, : Wiley-Blackwell, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The epigenetics of autoimmune diseases [[electronic resource] /] / edited by Moncef Zouali
| The epigenetics of autoimmune diseases [[electronic resource] /] / edited by Moncef Zouali |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, NJ, : Wiley-Blackwell, 2009 |
| Descrizione fisica | 1 online resource (473 p.) |
| Disciplina |
571.9/73
571.973 616.978042 |
| Altri autori (Persone) | ZoualiMoncef <1952-> |
| Soggetto topico |
Autoimmunity - Molecular aspects
Autoimmune diseases - Etiology Post-translational modification Epigenesis |
| ISBN |
1-282-13817-0
9786612138171 0-470-74355-7 0-470-74356-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
The Epigenetics of Autoimmune Diseases; Contents; Preface; Contributors; PART I Transcription Factors: Partners of Immune Tolerance to Self; 1 Transcriptional regulation of T cell tolerance; 1.1 Introduction; 1.2 T cell anergy; 1.3 Ca2+/calcineurin/NFAT signalling in T cell anergy; 1.4 Transcriptional programme of T cell anergy; 1.5 Transcriptional repression in T cell anergy: epigenetic modification of the Il2 promoter; 1.6 Regulatory T cells; 1.7 Transcriptional control of Treg development and function; References; 2 Epigenetic regulation of Foxp3 expression in regulatory T cells
2.1 Introduction2.2 Naturally occurring CD25+ CD4+ Tregs; 2.3 The transcription factor FOXP3: determining Treg function and identity; 2.4 Molecular regulation of FOXP3; 2.5 Tregs as a stable lineage: indications of epigenetic imprinting; 2.6 Induced Tregs: stable suppressors or transient immuno-modulators?; 2.7 Conclusions; References; 3 The role of NF-kB in central tolerance; 3.1 Introduction; 3.2 Canonical and alternative NF-kB pathways; 3.3 Thymic stroma and central tolerance; 3.4 NF-kB and regulatory T cell development; 3.5 NF-kB and thymocyte positive and negative selection 3.6 Conclusions and perspectives3.7 Acknowledgement; References; 4 The role of Act1 in the control of autoimmunity; 4.1 Introduction; 4.2 Autoimmunity and autoimmune mouse models; 4.3 Molecular mechanisms of autoimmunity; 4.4 Act1: a modulator of autoimmunity; 4.5 Conclusions; References; 5 Regulation of T cell anergy and escape from regulatory T cell suppression by Cbl-b; 5.1 Introduction; 5.2 Mechanisms of T cell tolerance induction; 5.3 Molecular establishment of T cell anergy; 5.4 Ubiquitin E3 ligases in T cell tolerance; 5.5 Molecular function and regulation of Cbl-b 5.6 Physiological relevance of Cbl-b5.7 The role of Cbl-b in T cell tolerance; 5.8 Deregulation of Cbl-b in disease; 5.9 Therapeutic potential of Cbl-b in tumour immunity; 5.10 Implications for autoimmune disease; References; 6 Indoleamine 2,3-dioxygenase: transcriptional regulation and autoimmunity; 6.1 Introduction; 6.2 L-Trp degradation along the kynurenine pathway and immune functions of IDO; 6.3 IDO immunobiology and therapeutic intervention; 6.4 Transcriptional regulation of the IDO-encoding gene; 6.5 Impaired IDO activity and loss of tolerance in autoimmune diseases 6.6 IDO-based therapies for autoimmune disease6.7 Acknowledgement; References; PART II Stress Responses that Break Immune Silence; 7 Chromatin modifications, oxidative stress and nucleosome autoantibodies; 7.1 Introduction; 7.2 Nucleosome and SLE; 7.3 Epigenetics and SLE; 7.4 Oxidative stress in SLE: definition and mechanisms; 7.5 Oxidative stress, epigenetic alterations and nucleosome immunogenicity; 7.6 Conclusion; 7.7 Acknowledgements; References; 8 Stress, epigenetics and thyroid autoimmunity; 8.1 Introduction; 8.2 The Th1/Th2 balance in immune-response regulation 8.3 Stress hormones and the Th1/Th2 balance |
| Record Nr. | UNINA-9910830763503321 |
| Chichester ; ; Hoboken, NJ, : Wiley-Blackwell, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The epigenetics of autoimmune diseases / / edited by Moncef Zouali
| The epigenetics of autoimmune diseases / / edited by Moncef Zouali |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, NJ, : Wiley-Blackwell, 2009 |
| Descrizione fisica | 1 online resource (473 p.) |
| Disciplina | 571.9/73 |
| Altri autori (Persone) | ZoualiMoncef <1952-> |
| Soggetto topico |
Autoimmunity - Molecular aspects
Autoimmune diseases - Etiology Post-translational modification Epigenesis |
| ISBN |
1-282-13817-0
9786612138171 0-470-74355-7 0-470-74356-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
The Epigenetics of Autoimmune Diseases; Contents; Preface; Contributors; PART I Transcription Factors: Partners of Immune Tolerance to Self; 1 Transcriptional regulation of T cell tolerance; 1.1 Introduction; 1.2 T cell anergy; 1.3 Ca2+/calcineurin/NFAT signalling in T cell anergy; 1.4 Transcriptional programme of T cell anergy; 1.5 Transcriptional repression in T cell anergy: epigenetic modification of the Il2 promoter; 1.6 Regulatory T cells; 1.7 Transcriptional control of Treg development and function; References; 2 Epigenetic regulation of Foxp3 expression in regulatory T cells
2.1 Introduction2.2 Naturally occurring CD25+ CD4+ Tregs; 2.3 The transcription factor FOXP3: determining Treg function and identity; 2.4 Molecular regulation of FOXP3; 2.5 Tregs as a stable lineage: indications of epigenetic imprinting; 2.6 Induced Tregs: stable suppressors or transient immuno-modulators?; 2.7 Conclusions; References; 3 The role of NF-kB in central tolerance; 3.1 Introduction; 3.2 Canonical and alternative NF-kB pathways; 3.3 Thymic stroma and central tolerance; 3.4 NF-kB and regulatory T cell development; 3.5 NF-kB and thymocyte positive and negative selection 3.6 Conclusions and perspectives3.7 Acknowledgement; References; 4 The role of Act1 in the control of autoimmunity; 4.1 Introduction; 4.2 Autoimmunity and autoimmune mouse models; 4.3 Molecular mechanisms of autoimmunity; 4.4 Act1: a modulator of autoimmunity; 4.5 Conclusions; References; 5 Regulation of T cell anergy and escape from regulatory T cell suppression by Cbl-b; 5.1 Introduction; 5.2 Mechanisms of T cell tolerance induction; 5.3 Molecular establishment of T cell anergy; 5.4 Ubiquitin E3 ligases in T cell tolerance; 5.5 Molecular function and regulation of Cbl-b 5.6 Physiological relevance of Cbl-b5.7 The role of Cbl-b in T cell tolerance; 5.8 Deregulation of Cbl-b in disease; 5.9 Therapeutic potential of Cbl-b in tumour immunity; 5.10 Implications for autoimmune disease; References; 6 Indoleamine 2,3-dioxygenase: transcriptional regulation and autoimmunity; 6.1 Introduction; 6.2 L-Trp degradation along the kynurenine pathway and immune functions of IDO; 6.3 IDO immunobiology and therapeutic intervention; 6.4 Transcriptional regulation of the IDO-encoding gene; 6.5 Impaired IDO activity and loss of tolerance in autoimmune diseases 6.6 IDO-based therapies for autoimmune disease6.7 Acknowledgement; References; PART II Stress Responses that Break Immune Silence; 7 Chromatin modifications, oxidative stress and nucleosome autoantibodies; 7.1 Introduction; 7.2 Nucleosome and SLE; 7.3 Epigenetics and SLE; 7.4 Oxidative stress in SLE: definition and mechanisms; 7.5 Oxidative stress, epigenetic alterations and nucleosome immunogenicity; 7.6 Conclusion; 7.7 Acknowledgements; References; 8 Stress, epigenetics and thyroid autoimmunity; 8.1 Introduction; 8.2 The Th1/Th2 balance in immune-response regulation 8.3 Stress hormones and the Th1/Th2 balance |
| Record Nr. | UNINA-9910877403103321 |
| Chichester ; ; Hoboken, NJ, : Wiley-Blackwell, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||